Literature DB >> 10593550

Increased cerebrospinal fluid glycine: a biochemical marker for a leukoencephalopathy with vanishing white matter.

M S van der Knaap1, R A Wevers, S Kure, F J Gabreëls, N M Verhoeven, B van Raaij-Selten, J Jaeken.   

Abstract

Recently, a new disease entity has been defined: the disease of vanishing white matter. This leukoencephalopathy has an autosomal-recessive mode of inheritance. No cause or biochemical marker is known. We studied cerebrospinal fluid amino acids in five patients with the disease and found a consistent, moderate elevation of cerebrospinal fluid glycine in all. The ratio of cerebrospinal fluid to plasma glycine was elevated in four patients, in two patients reaching the level considered diagnostic for nonketotic hyperglycinemia. The activity of the glycine cleavage system was found to be normal in lymphoblasts in two patients. The elevation of cerebrospinal fluid glycine in the disease of vanishing white matter is either caused by a primary disturbance of glycine metabolism or is secondary to excitotoxic brain damage.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10593550     DOI: 10.1177/088307389901401108

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  11 in total

1.  Forget About "van der Knaap syndrome," forget about glycine.

Authors:  Marjo S Van der Knaap
Journal:  AJNR Am J Neuroradiol       Date:  2003-05       Impact factor: 3.825

2.  Vacuolar leucoencephalopathy and pulvinar sign in association with coeliac disease.

Authors:  A M Ryan; J Ryan; M Wan-Ahmed; O Hardiman; M A Farrell; B McNamara; B J Sweeney
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-01       Impact factor: 10.154

3.  Demonstration of glycine peaks at 3.50 ppm in a patient with van der Knaap syndrome.

Authors:  R N Sener
Journal:  AJNR Am J Neuroradiol       Date:  2001-09       Impact factor: 3.825

Review 4.  MR spectroscopy: a powerful tool for investigating brain function and neurological diseases.

Authors:  A P Burlina; T Aureli; F Bracco; F Conti; L Battistin
Journal:  Neurochem Res       Date:  2000-10       Impact factor: 3.996

5.  Vacuolar leucoencephalopathy and pulvinar sign in association with coeliac disease.

Authors:  A M Ryan; J Ryan; M Wan-Ahmed; O Hardiman; M A Farrell; B McNamara; B J Sweeney
Journal:  BMJ Case Rep       Date:  2009-01-23

Review 6.  Tools for diagnosis of leukodystrophies and other disorders presenting with white matter disease.

Authors:  Adeline Vanderver
Journal:  Curr Neurol Neurosci Rep       Date:  2005-03       Impact factor: 5.081

7.  Sensitivity and specificity of decreased CSF asialotransferrin for eIF2B-related disorder.

Authors:  A Vanderver; Y Hathout; J Maletkovic; E S Gordon; M Mintz; M Timmons; E P Hoffman; L Horzinski; F Niel; A Fogli; O Boespflug-Tanguy; R Schiffmann
Journal:  Neurology       Date:  2008-06-03       Impact factor: 9.910

8.  Vanishing white matter: deregulated integrated stress response as therapy target.

Authors:  Truus E M Abbink; Lisanne E Wisse; Ermelinda Jaku; Michiel J Thiecke; Daniel Voltolini-González; Hein Fritsen; Sander Bobeldijk; Timo J Ter Braak; Emiel Polder; Nienke L Postma; Marianna Bugiani; Eduard A Struijs; Mark Verheijen; Nina Straat; Sophie van der Sluis; Adri A M Thomas; Douwe Molenaar; Marjo S van der Knaap
Journal:  Ann Clin Transl Neurol       Date:  2019-07-18       Impact factor: 4.511

9.  Startle Seizures and Diffuse Leukoencephalopathy After Resolution of Herpes Simplex Virus 1 Encephalitis in a Child.

Authors:  Andy Cheuk-Him Ng; Janani Kassiri; Helly R Goez; Francois Morneau-Jacob; Janette Mailo
Journal:  Child Neurol Open       Date:  2022-03-24

10.  LEUKOENCEPHALOPATHY WITH EVANESCENT WHITE MATTER: A CASE REPORT.

Authors:  Renata Porciuncula; Patricia Kelly Wilmsen Dalla Santa Spada; Karen Olivia Bazzo Goulart
Journal:  Rev Paul Pediatr       Date:  2018-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.